Scynexis Inc (SCYX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt SCYX? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Scynexis Inc Stock (SCYX) Company Profile

Scynexis Inc

Healthcare (1087)

201-884-5485

1 EVERTRUST PLAZA, JERSEY CITY, NJ

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SCYX's Discussions on Twitter

Compare SCYX vs TAK, TEVA, HLN, ZTS, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SCYX Scynexis Inc	4.96	51.24M	20.34M	-24.52M	-5.92M	-3.5761
TAK Takeda Pharmaceutical Co Adr	18.25	58.50B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	36.76	42.84B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.185	40.68B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	73.57	30.40B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	503.32	21.36B	3.17B	1.29B	1.01B	27.09

Scynexis Inc Stock (SCYX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2021-01-22	Eingeleitet	Guggenheim	Buy
2021-01-06	Eingeleitet	Cantor Fitzgerald	Overweight
2018-07-11	Hochstufung	Needham	Hold → Buy
2018-06-27	Eingeleitet	Maxim Group	Buy
2017-10-24	Eingeleitet	Guggenheim	Buy
2017-07-10	Eingeleitet	ROTH Capital	Buy
2017-05-09	Herabstufung	Needham	Buy → Hold
2017-03-03	Bestätigt	RBC Capital Mkts	Outperform
2016-10-20	Eingeleitet	H.C. Wainwright	Buy
2016-10-07	Hochstufung	WBB Securities	Buy → Strong Buy
2016-10-03	Fortgesetzt	Brean Capital	Buy
2016-08-17	Eingeleitet	Guggenheim	Buy
2016-08-09	Bestätigt	Needham	Buy
2016-08-09	Hochstufung	WBB Securities	Speculative Buy → Buy
2016-03-28	Eingeleitet	Brean Capital	Buy
2015-12-29	Eingeleitet	WBB Securities	Speculative Buy
2015-11-16	Bestätigt	RBC Capital Mkts	Outperform
2015-06-10	Eingeleitet	Needham	Buy
2014-05-29	Eingeleitet	Canaccord Genuity	Buy
2014-05-29	Eingeleitet	RBC Capital Mkts	Outperform

Alle ansehen

Scynexis Inc Aktie (SCYX) Neueste Nachrichten

Finanzdaten der Scynexis Inc-Aktie (SCYX)

Scynexis Inc (SCYX)

Scynexis Inc Stock (SCYX) Company Profile

Compare SCYX vs TAK, TEVA, HLN, ZTS, UTHR

Scynexis Inc Stock (SCYX) Upgrades & Downgrades

Scynexis Inc Aktie (SCYX) Neueste Nachrichten

SCYNEXIS Inc. (SCYX) Advances 1.92% to $5.32 as Stock Holds Above Key $5.05 SupportDiamond Pattern - vinanet.vn

Scynexis Inc (SCYX) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research

SCYNEXIS, Inc. (SCYX) latest stock news and headlines - Yahoo Finance Australia

SCYNEXIS to Participate in Upcoming Investor Conferences - The Manila Times

Scynexis Inc (SCYX) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

SCYNEXIS Announces Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com

Press Release: SCYNEXIS Announces Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - Moomoo

SCYNEXIS (SCYX) Market: Moves 3.60% Up to $5.33; Boundary Watch: the Near-Term Reference Band Stretches From $5.06 to $5.60 under the Current SnapshotShort Setup Alerts - vinanet.vn

SCYNEXIS (NASDAQ:SCYX) Upgraded at Wall Street Zen - MarketBeat

SCYX Q1 2026 Earnings: Deep EPS Miss and Missing Revenue Put Pipeline Execution in FocusEstimate Dispersion - vinanet.vn

SCYNEXIS (SCYX) investors CVI and Heights disclose 5.9% ownership stake - Stock Titan

Revenue per share of SCYNEXIS, Inc. – DUS:135 - TradingView

Free cash flow per share of SCYNEXIS, Inc. – DUS:135 - TradingView

SCYNEXIS, Inc. Earnings and Revenue – DUS:135 - TradingView

135 Forecast — Price Target — Prediction for 2027 - TradingView

SCYNEXIS, Inc.: Fundamental Analysis and Financial Ratings | 135 | US8112923094 - marketscreener.com

Great Point Partners (SCYX) reports 9.99% beneficial stake in Scynexis - Stock Titan

Results: SCYNEXIS, Inc. Confounded Analyst Expectations With A Surprise Profit - simplywall.st

SCYX Maintained by Guggenheim -- Price Target Raised to $33.00 - GuruFocus

Guggenheim raises Scynexis stock price target to $33 on drug potential - Investing.com Nigeria

Adage Capital group (SCYX) discloses 1,041,824-share SCYNEXIS stake including warrants - Stock Titan

Scynexis Inc earnings beat by $1.14, revenue topped estimates - Investing.com Nigeria

SCYNEXIS Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times

SCYX Looks 78.3% Undervalued on GF Value™ Despite Challenging Fu - GuruFocus

Scynexis Q2 adjusted EPS misses estimate as sales decline 82.77% - scanx.trade

Scynexis: Q2 Earnings Snapshot - AOL.com

SCYNEXIS (NASDAQ:SCYX) Announces Quarterly Earnings Results, Beats Expectations By $1.14 EPS - marketbeat.com

Scynexis Q2 swings to profit on warrant adjustment; advances drug studies - TradingView

Scynexis (NASDAQ: SCYX) lifts cash and pipeline with Q2 2026 moves - Stock Titan

SCYNEXIS, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

SCYNEXIS (NASDAQ:SCYX) Lowered to Strong Sell Rating by Wall Street Zen - MarketBeat

SCYNEXIS Inc expected to post a loss of 51 cents a shareEarnings Preview - TradingView

SCYNEXIS Inc. R (135.MU) insider ownership and holdings - Yahoo Finance Australia

SCYNEXIS Inc (SCYX) Stock News Today - TradingKey

SCYNEXIS Inc (SCYX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

SCYNEXIS (SCYX) Projected to Post Quarterly Earnings on Wednesday - MarketBeat

Scynexis Deadline Alert - TMX Newsfile

SCYX Q1 2026 Earnings: Wider-Than-Expected Loss of -$3.36 Per Share, Yet Stock Climbs 30.46%Segment Revenue Breakdown - vinanet.vn

Scynexis stock price target reiterated at $44.64 by Brookline - Investing.com Nigeria

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

SCYNEXIS Inc (SCYX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

SCYNEXIS Inc (SCYX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

SCYX|SCYNEXIS Inc|Price:3.560|Chg%:-0.170 - TradingKey

SCYNEXIS Inc (SCYX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

SCYNEXIS Inc (SCYX) Balance Sheet - TradingKey

SCYNEXIS Inc (SCYX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

TradingKey - TradingKey

SCYNEXIS Inc (SCYX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

SCYNEXIS Inc (SCYX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

SCYNEXIS (SCYX) Slips 5.8% as Biotech Stock Nears Critical Support at $3.54Insider Selling Alerts - Vinanet

Finanzdaten der Scynexis Inc-Aktie (SCYX)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie SCYX